These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15353125)
1. A novel protein-DNA interaction involved with the CpG dinucleotide at -30 upstream is linked to the DNA methylation mediated transcription silencing of the MAGE-A1 gene. Zhang J; Yu J; Gu J; Gao BM; Zhao YJ; Wang P; Zhang HY; De Zhu J Cell Res; 2004 Aug; 14(4):283-94. PubMed ID: 15353125 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Stirzaker C; Song JZ; Davidson B; Clark SJ Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996 [TBL] [Abstract][Full Text] [Related]
3. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC. Qiu G; Fang J; He Y Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880 [TBL] [Abstract][Full Text] [Related]
4. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element. Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959 [TBL] [Abstract][Full Text] [Related]
5. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters. Wischnewski F; Friese O; Pantel K; Schwarzenbach H Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428 [TBL] [Abstract][Full Text] [Related]
6. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801 [TBL] [Abstract][Full Text] [Related]
7. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390 [TBL] [Abstract][Full Text] [Related]
8. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Nakagawachi T; Soejima H; Urano T; Zhao W; Higashimoto K; Satoh Y; Matsukura S; Kudo S; Kitajima Y; Harada H; Furukawa K; Matsuzaki H; Emi M; Nakabeppu Y; Miyazaki K; Sekiguchi M; Mukai T Oncogene; 2003 Dec; 22(55):8835-44. PubMed ID: 14647440 [TBL] [Abstract][Full Text] [Related]
9. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589 [TBL] [Abstract][Full Text] [Related]
10. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines]. Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987 [TBL] [Abstract][Full Text] [Related]
11. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients. Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393 [TBL] [Abstract][Full Text] [Related]
12. [Expression of MAGE-A1 in human hepatoma cell lines associated with genic hypomethylation]. Xiao J; Chen HS; Fei R; Cong X; Wang Y; Jiang D; Wei L; Wang Y Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):351-4. PubMed ID: 15918969 [TBL] [Abstract][Full Text] [Related]
13. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin. Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188 [TBL] [Abstract][Full Text] [Related]
15. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857 [TBL] [Abstract][Full Text] [Related]
16. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Strunnikova M; Schagdarsurengin U; Kehlen A; Garbe JC; Stampfer MR; Dammann R Mol Cell Biol; 2005 May; 25(10):3923-33. PubMed ID: 15870267 [TBL] [Abstract][Full Text] [Related]
17. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146 [TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle. Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269 [TBL] [Abstract][Full Text] [Related]
19. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956 [TBL] [Abstract][Full Text] [Related]
20. Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements. Kondoh N; Hada A; Ryo A; Shuda M; Arai M; Matsubara O; Kimura F; Wakatsuki T; Yamamoto M Int J Oncol; 2003 Dec; 23(6):1575-83. PubMed ID: 14612929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]